Business
Canopy Growth to Report Second Quarter Fiscal 2021 Financial Results on November 9, 2020
Canopy Growth to Report Second Quarter Fiscal 2021 Financial Results on November 9, 2020 ...
About this update from Canopy Growth Corporation
[{"type":"text","content":"\n \n \n \n Canopy Growth to Report Second Quarter Fiscal 2021 Financial Results on November 9, 2020\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n SMITHS FALLS, ON, Nov. 2, 2020\n \n \n \n \n \n SMITHS FALLS, ON\n \n ,\n \n Nov. 2, 2020\n \n /CNW/ - Canopy Growth Corporation (\"Canopy Growth\" or the \"Company\") (TSX: WEED) (NYSE: CGC) will release its financial results for the second quarter fiscal 2021 ended\n \n September 30, 2020\n \n before financial markets open on\n \n November 9, 2020\n \n .\n \n \n \n \n \n \n \n \n \n Following the release of its second quarter fiscal 2021 financial results, Canopy Growth will host an audio webcast with\n \n David Klein\n \n , CEO and\n \n Mike Lee\n \n , EVP & CFO at\n \n 10:00 AM Eastern Time\n \n on\n \n November 9, 2020\n \n .\n \n \n \n Webcast Information\n \n \n A live audio webcast will be available at:\n \n \n \n https://produceredition.webcasts.com/starthere.jsp?ei=1384068&tp_key=9317fbfde9\n \n \n \n \n \n Replay Information\n \n \n A replay will be accessible by webcast until\n \n 11:59 PM ET\n \n on\n \n February 7, 2021\n \n at:\n \n \n \n https://produceredition.webcasts.com/starthere.jsp?ei=1384068&tp_key=9317fbfde9\n \n \n \n \n \n About Canopy Growth Corporation\n \n \n Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth's subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.\n \n \n Canopy Growth's medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and has devoted millions of dollars toward cutting ...